Spots Global Cancer Trial Database for H.O.P.E: Helping Ovarian Cancer Patients Cope

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: H.O.P.E: Helping Ovarian Cancer Patients Cope

Official Title: Pilot Study on H.O.P.E: Helping Ovarian Cancer Patients Cope During Disease Recurrence

Study ID: NCT02090582

Conditions

Platinum-resistant Ovarian Cancer

Recurrent Ovarian Cancer

Palliative Care

Interventions

Structured Palliative Care

Usual Care

Study Description

Brief Summary: The purpose of this study is to test the effect of the gynecologic oncologists with palliative care specialist collaboration (GO-PC) intervention on patient quality of life.

Detailed Description: Eligible patients include women diagnosed with platinum-resistant ovarian cancer or recurrent ovarian cancer cancer. All patient participants will complete two quality of life (QOL) questionnaires and a cost-diary documenting their health care experience at time of consent and every 12 weeks thereafter. Consenting care givers will also be asked to complete two questionnaires to asses the impact of structured palliative care on them every 12 weeks. Patients will be assigned to two arms randomly: 1) usual care or 2) structured palliative care. The primary endpoint is quality of life. A two-sided Chi-square test will be used to compare the proportion of patients who have improved quality of life after treatment between control arm and intervention arm. The average value of multiple scores after treatment will be used to compare with the baseline score before treatment for each question in the standard questionnaire.